Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

Interventional Medicine & Applied Science
Anand MauryaRajendra Awasthi

Abstract

Since the development of first lipid-based nanocarrier system, about 15% of the present pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is an advanced area to meliorate the delivery of compounds for improved medical diagnosis and curing disease. Nanomedicines are gaining significant interest due to the ultra small size and large surface area to mass ratio. In this review, we discuss the potential of nanotechnology in delivering of active moieties for the disease therapy including their toxicity evidences. This communication will help the formulation scientists in understanding and exploring the new aspects of nanotechnology in the field of nanomedicine.

References

Dec 9, 1993·The New England Journal of Medicine·D W DockeryF E Speizer
Jan 21, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·S L LawC H Chiang
Jul 9, 2002·Biochimica Et Biophysica Acta·Jennifer J SudimackRobert J Lee
Aug 1, 2002·Leukemia & Lymphoma·Min-Fu TsanG Chikkappa
Aug 7, 2002·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Govind J KapadiaHoyoku Nishino
Oct 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cristina FonsecaRogério Gaspar
Jan 29, 2003·International Journal of Pharmaceutics·R JevprasesphantA D'Emanuele
Feb 21, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Elaine Merisko-LiversidgeEugene R Cooper
Jul 4, 2003·The Journal of Nutrition·Jubilee R StewartCatherine A O'Brian
Sep 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sudaxshina Murdan
Sep 30, 2003·Journal of Toxicology and Environmental Health. Part a·Anna A ShvedovaPaul Baron
Sep 30, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Chiu-Wing LamRobert L Hunter
Sep 30, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·D B WarheitT R Webb
Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·L R HirschJ L West
Dec 6, 2003·Circulation·Denis B BuxtonUNKNOWN National Heart, Lung, and Blood Institute Nanotechnology Working Group
Jan 31, 2004·Technology in Cancer Research & Treatment·Christopher LooRebekah Drezek
Feb 6, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kevin L Dreher
Feb 18, 2004·Current Medicinal Chemistry·Si-Shen FengGuofeng Huang
Mar 17, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Antony D'EmanueleDavid Attwood
Apr 1, 2004·International Journal of Cancer. Journal International Du Cancer·Paul J A BormCatrin Albrecht
Apr 15, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·R Neslihan Gursoy, Simon Benita
May 26, 2004·Cancer Letters·D Patrick O'NealJennifer L West
Jun 3, 2004·Circulation·Robert D BrookUNKNOWN Expert Panel on Population and Prevention Science of the American Heart Association
Jun 19, 2004·Inhalation Toxicology·G OberdörsterC Cox
Aug 12, 2004·Journal of the American Chemical Society·Hui-Ting ChenEric E Simanek
Sep 8, 2004·International Journal of Cancer. Journal International Du Cancer·Sanjeeb K SahooVinod Labhasetwar
Sep 24, 2004·Microbiology and Immunology·Amane ShioharaKenji Yamamoto
Oct 29, 2004·Physics in Medicine and Biology·James F HainfeldHenry M Smilowitz
Nov 9, 2004·Chemistry and Physics of Lipids·Almut MeckeMark M Banaszak Holl
Jan 15, 2005·Toxicology Letters·Nancy A Monteiro-RiviereJim E Riviere
Feb 3, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jasmina LovrićDusica Maysinger
Mar 30, 2005·Nano Letters·Christian KirchnerWolfgang J Parak
Aug 27, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Michael P HolsappleKarluss V Thomas
Aug 30, 2005·International Journal of Pharmaceutics·Hirofumi TakeuchiYoshiaki Kawashima
Sep 1, 2005·Toxicology and Applied Pharmacology·Julie MullerDominique Lison
Sep 15, 2005·British Journal of Pharmacology·Anna RadomskiMarek W Radomski
Oct 19, 2005·Toxicology Letters·Christie M SayesVicki L Colvin
Nov 22, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ji-Yeon HongChong-Kook Kim

❮ Previous
Next ❯

Citations

Sep 24, 2019·Recent Patents on Drug Delivery & Formulation·Rachna RanaGiriraj T Kulkarni
Aug 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Aleksandra ZielińskaEliana B Souto
May 14, 2021·Frontiers in Chemistry·Neerupma DhimanGiriraj T Kulkarni
Feb 10, 2021·Allergy·Cristobalina MayorgaMaria Isabel Montañez

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft

Software Mentioned

SNEDDS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Canadian Veterinary Journal. La Revue Vétérinaire Canadienne
Carlton Gyles
JAMA : the Journal of the American Medical Association
Robert Langer, Ralph Weissleder
Current Opinion in Chemical Biology
Andrew J deMello, Adam T Woolley
Advances in Chronic Kidney Disease
William H Fissell
Journal of Drugs in Dermatology : JDD
Macrene Alexiades-Armenakas
© 2021 Meta ULC. All rights reserved